Literature DB >> 464663

Lymphocyte proliferation during PUVA therapy.

G Lischka.   

Abstract

The lymphocyte proliferation of 15 psoriatic patients was sutdied after stimulation with tuberculin, trichophytin, varidase, concanavalin A (Con A), and pokeweek mitogen (PMW) during the first and the eighth PUVA treatment, 2 h after oral intake of 8-methoxypsoralen (8-MOP), immediately after UVA-irradiation, and 24 h later. There was a significant decrease of the lymphocyte proliferation, after stimulation with Con A (P less than 0.05), trichophytin (P less than 0.01) and varidase (P less than 0.05), not with PWM and tuberculin, during the first PUVA treatment by 8-MOP alone. This decrease was not significantly changed by the following UVA irradiation and could not be demonstrated after 24 h. No dark effect of 8-MOP on the lymphocyte proliferation could be seen during the eighth treatment. 8-MOP seems to influence lymphocyte proliferation in the dark by interfering with the cell surface, not with the nucleus. The disappearence of this effect during PUVA therapy could be explained by a modification on the surface structure of lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 464663     DOI: 10.1007/bf00407887

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  9 in total

1.  [Photochemotherapy of psoriasis using 8-methoxypsoralen and UVA. II. Binding of the photosensitizator to protein].

Authors:  H Meffert; W Diezel; W Günther; N Sönnichsen
Journal:  Dermatol Monatsschr       Date:  1976-11

2.  [Effects of UV-C and of 8-MOP + UV-A on the T- and B-population of human lymphocytes in vitro (author's transl)].

Authors:  E Bohnert; G Bächtold; G Lischka; E G Jung
Journal:  Arch Dermatol Res       Date:  1977-10-27       Impact factor: 3.017

3.  Decrease in neutrophils observed in vivo in psoriatics after PUVA therapy.

Authors:  K B Dahl; A Nyfors; H Brodthagen
Journal:  Arch Dermatol Res       Date:  1978-06-29       Impact factor: 3.017

4.  Impairement of thymus derived rosette forming cells during photochemotherapy (psoralen--U.V.A.).

Authors:  J P Ortonne; A Claudy; A Alario; J Thivolet
Journal:  Arch Dermatol Res       Date:  1978-07-28       Impact factor: 3.017

5.  Effects of 8-methoxypsoralen (8-MOP) and UVA on human lymphocytes.

Authors:  G Lischka; E Bohnert; G Bächtold; E G Jung
Journal:  Arch Dermatol Res       Date:  1977-09-27       Impact factor: 3.017

6.  [Photochemotherapy with 8-methoxypsoralen and UVA. III. Fluorescent microscopy studies of binding and transport of 8-MOP in the human skin].

Authors:  H Meffert; H Varthelmes; D Metz; N Sönnichsen
Journal:  Dermatol Monatsschr       Date:  1977-08

7.  The human peripheral lymphocyte--a model system for studying the combined effect of psoralen plus black light.

Authors:  R Scherer; B Kern; O Braun-Falco
Journal:  Klin Wochenschr       Date:  1977-02-01

8.  UVA-induced inhibition of proliferation of PHA-stimulated lymphocytes from humans treated with 8-methoxypsoralen.

Authors:  R Scherer; B Kern; O Braun-Falco
Journal:  Br J Dermatol       Date:  1977-11       Impact factor: 9.302

9.  Dark effect of 8-methoxypsoralen (8-MOP) on lymphocytes.

Authors:  G Lischka; E Decker
Journal:  Arch Dermatol Res       Date:  1978-05-31       Impact factor: 3.017

  9 in total
  3 in total

1.  [DNA-repair of lymphocytes during PUVA-treatment (author's transl)].

Authors:  E Bohnert; W G Humbel
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

2.  Enhancement of cutaneous delayed hypersensitivity reactions by a single exposure to UV-A or PUVA.

Authors:  S Moberg; H Mobacken
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

3.  Autoradiographic and planimetric analyses of the inflammatory infiltrate in psoriatic lesions under PUVA-therapy.

Authors:  M Landthaler; G Plewig; C Hofmann; O Braun-Falco
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.